Therapeutic Effect of Renifolin F on Airway Allergy in an Ovalbumin-Induced Asthma Mouse Model In Vivo
Open Access
Abstract
Renifolin F is a prenylated chalcone isolated from Shuteria involucrata, a traditional minority ethnic medicine used to treat the respiratory diseases and asthma. Based on the effects of the original medicine plant, we established an in vivo mouse model of allergic asthma using ovalbumin (OVA) as an inducer to evaluate the therapeutic effects of Renifolin F. In the research, mice were sensitized and challenged with OVA to establish an allergic asthma model to evaluate the effects of Renifolin F on allergic asthma. The airway hyper-reactivity (AHR) to methacholine, cytokine levels, ILC2s quantity and mircoRNA-155 expression were assessed. We discovered that Renifolin F attenuated AHR and airway inflammation in the OVA-induced asthmatic mouse model by inhibiting the regulation of ILC2s in the lung, thereby, reducing the upstream inflammatory cytokines IL-25, IL-33 and TSLP; the downstream inflammatory cytokines IL-4, IL-5, IL-9 and IL-13 of ILC2s; and the co-stimulatory factors IL-2 and IL-7; as well as the expression of microRNA-155 in the lung. The findings suggest a therapeutic potential of Renifolin F on OVA-induced airway inflammation.Keywords
Funding Information
- National Natural Science Foundation of China (81960778, 82060751, 202205AC160039, 2019FF002-009, 2019FA035, 2017HC011)
- Middle-Aged Academic and Technical Leaders of Yunnan Province (81960778, 82060751, 202205AC160039, 2019FF002-009, 2019FA035, 2017HC011)
- Yunnan Provincial Science and Technology Department-Applied Basic Research Joint Special Funds of Chinese Medicine (81960778, 82060751, 202205AC160039, 2019FF002-009, 2019FA035, 2017HC011)
- Key Project of Yunnan Provincial Science and Technology Department (81960778, 82060751, 202205AC160039, 2019FF002-009, 2019FA035, 2017HC011)
- Yunnan Innovation Team of Application Research on TCM Theory of Prevention Disease at Yunnan University of TCM (81960778, 82060751, 202205AC160039, 2019FF002-009, 2019FA035, 2017HC011)
This publication has 50 references indexed in Scilit:
- Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related DiseasesInternational Journal of Molecular Sciences, 2016
- Synergistically increased ILC2 and Th9 cells in lung tissue jointly promote the pathological process of asthma in miceMolecular Medicine Reports, 2016
- Type 2 innate lymphoid cells: at the cross-roads in allergic asthmaSeminars in Immunopathology, 2016
- Two new chalcones fromShuteria sinensisNatural Product Research, 2015
- Five new prenylated chalcones from Desmodium renifoliumFitoterapia, 2014
- Differentiation of Type 1 ILCs from a Common Progenitor to All Helper-like Innate Lymphoid Cell LineagesCell, 2014
- Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammationNature Communications, 2013
- The emerging role of microRNAs in regulating immune and inflammatory responses in the lungImmunological Reviews, 2013
- IgE, mast cells, basophils, and eosinophilsJournal of Allergy and Clinical Immunology, 2010
- Eotaxin and asthmaCurrent Opinion in Pharmacology, 2001